Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Fishbein

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|October 3, 2015
Systematic donor selection review process improves cardiac transplant volumes and outcomesJason W Smith, Kevin D O'Brien, Todd Dardas, et al.
JACC. Clinical Electrophysiology|August 25, 2018
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk EstimatesWayne C Levy, Anne S Hellkamp, Daniel B Mark, et al.
Circulation|August 26, 2009
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure populationWayne C Levy, Kerry L Lee, Anne S Hellkamp, et al.
Journal of the American College of Cardiology|July 25, 2020
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFTJeanne E Poole, Brian Olshansky, Daniel B Mark, et al.
The New England Journal of Medicine|January 22, 2005
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureGust H Bardy, Kerry L Lee, Daniel B Mark, et al.
The New England Journal of Medicine|September 5, 2008
Prognostic importance of defibrillator shocks in patients with heart failureJeanne E Poole, George W Johnson, Anne S Hellkamp, et al.
The American Journal of Cardiology|January 27, 2005
Statin use and risks of death or fatal rejection in the Heart Transplant Lipid RegistryAudrey H Wu, Christie M Ballantyne, Beth C Short, et al.
Journal of the American College of Cardiology|June 6, 2006
Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failureMilton Packer, William T Abraham, Mandeep R Mehra, et al.
Medrxiv : the Preprint Server for Health Sciences|December 9, 2024
Implementing Precision Medicine for Dilated Cardiomyopathy: Insights from The DCM ConsortiumElizabeth Jordan, Hanyu Ni, Patricia Parker, et al.
Journal of the American College of Cardiology|May 24, 2023
Screening for Dilated Cardiomyopathy in At-Risk First-Degree RelativesHanyu Ni, Elizabeth Jordan, Daniel D Kinnamon, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Thoracic and Cardiovascular Surgery|October 3, 2015
Systematic donor selection review process improves cardiac transplant volumes and outcomesJason W Smith, Kevin D O'Brien, Todd Dardas, et al.
JACC. Clinical Electrophysiology|August 25, 2018
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk EstimatesWayne C Levy, Anne S Hellkamp, Daniel B Mark, et al.
Circulation|August 26, 2009
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure populationWayne C Levy, Kerry L Lee, Anne S Hellkamp, et al.
Journal of the American College of Cardiology|July 25, 2020
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFTJeanne E Poole, Brian Olshansky, Daniel B Mark, et al.
The New England Journal of Medicine|January 22, 2005
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureGust H Bardy, Kerry L Lee, Daniel B Mark, et al.
The New England Journal of Medicine|September 5, 2008
Prognostic importance of defibrillator shocks in patients with heart failureJeanne E Poole, George W Johnson, Anne S Hellkamp, et al.
The American Journal of Cardiology|January 27, 2005
Statin use and risks of death or fatal rejection in the Heart Transplant Lipid RegistryAudrey H Wu, Christie M Ballantyne, Beth C Short, et al.
Journal of the American College of Cardiology|June 6, 2006
Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failureMilton Packer, William T Abraham, Mandeep R Mehra, et al.
Medrxiv : the Preprint Server for Health Sciences|December 9, 2024
Implementing Precision Medicine for Dilated Cardiomyopathy: Insights from The DCM ConsortiumElizabeth Jordan, Hanyu Ni, Patricia Parker, et al.
Journal of the American College of Cardiology|May 24, 2023
Screening for Dilated Cardiomyopathy in At-Risk First-Degree RelativesHanyu Ni, Elizabeth Jordan, Daniel D Kinnamon, et al.
Pageof 3